Literature DB >> 17078909

Imaging and quantifying valvular heart disease using magnetic resonance techniques.

George E Gentchos1, Marc D Tischler, Timothy F Christian.   

Abstract

Echocardiography remains the cornerstone of noninvasive valvular heart disease evaluation. There are instances where MRI can be of use. Aside from the obvious advantage where limited acoustic windows are present, cardiac magnetic resonance (CMR) allows for imaging in any desired plane, and advantage can be taken of the ability to align with any regurgitant or stenotic flow jet. The high spatial resolution and contrast allow for accurate detail of valvular anatomy, but it must be remembered that the images represent a composite of eight to 12 heart cycles. For visualizing multiple valvular abnormalities simultaneously, cardiac MRI has a distinct advantage. Finally, a CMR valvular examination can be combined with accurate assessments of left and right ventricular function, myocardial stress perfusion imaging, and detailed viability determinations in a single examination. This provides a comprehensive presurgical evaluation of cardiac physiology.

Entities:  

Year:  2006        PMID: 17078909     DOI: 10.1007/s11936-006-0033-7

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  27 in total

1.  Quantification of stenotic mitral valve area with magnetic resonance imaging and comparison with Doppler ultrasound.

Authors:  Shiow Jiuan Lin; Peggy A Brown; Mary P Watkins; Todd A Williams; Katherine A Lehr; Wei Liu; Gregory M Lanza; Samuel A Wickline; Shelton D Caruthers
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

2.  Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques.

Authors:  Mark W S Kon; Saul G Myerson; Neil E Moat; Dudley J Pennell
Journal:  J Heart Valve Dis       Date:  2004-07

3.  The importance of slice location on the accuracy of aortic regurgitation measurements with magnetic resonance phase velocity mapping.

Authors:  G P Chatzimavroudis; P G Walker; J N Oshinski; R H Franch; R I Pettigrew; A P Yoganathan
Journal:  Ann Biomed Eng       Date:  1997 Jul-Aug       Impact factor: 3.934

4.  Comparison of cine MR imaging with Doppler echocardiography for the evaluation of aortic regurgitation.

Authors:  P W Pflugfelder; J S Landzberg; M M Cassidy; M D Cheitlin; N B Schiller; W Auffermann; C B Higgins
Journal:  AJR Am J Roentgenol       Date:  1989-04       Impact factor: 3.959

5.  Motion correction for the quantification of mitral regurgitation using the control volume method.

Authors:  P G Walker; K Houlind; C Djurhuus; W Y Kim; E M Pedersen
Journal:  Magn Reson Med       Date:  2000-05       Impact factor: 4.668

Review 6.  MR imaging of metallic implants and materials: a compilation of the literature.

Authors:  F G Shellock
Journal:  AJR Am J Roentgenol       Date:  1988-10       Impact factor: 3.959

7.  Magnetic resonance imaging assessment of the severity of mitral regurgitation. Comparison with invasive techniques.

Authors:  W G Hundley; H F Li; J E Willard; C Landau; R A Lange; B M Meshack; L D Hillis; R M Peshock
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

8.  Severity of aortic regurgitation: interstudy reproducibility of measurements with velocity-encoded cine MR imaging.

Authors:  M C Dulce; G H Mostbeck; M O'Sullivan; M Cheitlin; G R Caputo; C B Higgins
Journal:  Radiology       Date:  1992-10       Impact factor: 11.105

9.  Practical value of cardiac magnetic resonance imaging for clinical quantification of aortic valve stenosis: comparison with echocardiography.

Authors:  Shelton D Caruthers; Shiow Jiuan Lin; Peggy Brown; Mary P Watkins; Todd A Williams; Katherine A Lehr; Samuel A Wickline
Journal:  Circulation       Date:  2003-10-20       Impact factor: 29.690

10.  Aortic valve pressure gradients in patients with aortic valve stenosis: quantification with velocity-encoded cine MR imaging.

Authors:  A C Eichenberger; R Jenni; G K von Schulthess
Journal:  AJR Am J Roentgenol       Date:  1993-05       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.